(1)
Budget Impact Analysis of Apixaban Versus Other NOACs for the Prevention of Stroke in Italian Atrial Fibrillation Patients. FE 2014, 15 (1S), 5-14. https://doi.org/10.7175/fe.v15i1s.973.